2. The drug behind Europe's most valuable com...

Why hasn’t there been a dramatic increase in the price of oil since Iran’s retaliation aimed at key oil facilities and waterways? Are investors right not to worry too much yet? What will it take to end this? And following Trump’s fury at Starmer over his reluctance to let them us ...  Show more

What are the consequences for oil and gas prices of Iran’s retaliation? Will the primary impact be higher inflation or lower growth, and what does this mean for interest rates? And are we heading for a stock market crash? Robert and Steph also explain why the war is a nightmare f ...  Show more

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Episode 146: Neal and Toby list off all the exciting tidbits from Apple's big product event, including the iPhone 15 reveal. Next, how a covid-era government program is affecting poverty rates in America. Plus, quick relief from a cold may be gone as FDA declares a key ingredient ...  Show more

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ...

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ...  Show more